0000885590-15-000001.txt : 20150102
0000885590-15-000001.hdr.sgml : 20150102
20150102160314
ACCESSION NUMBER: 0000885590-15-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141230
FILED AS OF DATE: 20150102
DATE AS OF CHANGE: 20150102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kellen Ari
CENTRAL INDEX KEY: 0001595698
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 15501422
MAIL ADDRESS:
STREET 1: 700 ROUTE 202 606 NORTH
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2014-12-30
0
0000885590
Valeant Pharmaceuticals International, Inc.
VRX
0001595698
Kellen Ari
400 SOMERSET CORPORATE BOULEVARD
BRIDGEWATER
NJ
08807
0
1
0
0
EVP, Company Group Chairman
Restricted Share Units
2014-12-30
4
D
0
75000
D
Common Shares, no par value
0
0
D
Restricted Share Units
2014-12-30
4
A
0
75000
A
Common Shares, no par value
225000
75000
D
Each Restricted Share Unit represents a contingent right to receive between zero and three common shares, no par value, of Valeant Pharmaceuticals International, Inc. ("Valeant"), subject to performance based vesting criteria. See note (3).
Amendment to the original Restricted Share Units ("RSUs") due to change in measurement dates as approved by the Talent and Compensation Committee of the Board of Directors.
The performance based RSUs are eligible to vest on the achievement of TSR targets ranging from 10% to 30% over a base price of $107.96 on each of three measurement dates: 25% would vest on October 9, 2018, 50% on January 9, 2019 and 25% on April 9, 2019, with early vesting possible at higher TSR levels.
The performance based RSUs are eligible to vest on the achievement of TSR targets ranging from 10% to 30% over a base price of $107.96 on each of three measurement dates: 25% would vest on October 9, 2016, 50% on January 9, 2017 and 25% on April 9, 2017, with early vesting possible at higher TSR levels.
Represents the maximum number of Common Shares that may be issued under the RSU award. See note (4).
by: Nicholas Zanoni for Ari Kellen
2015-01-02